Figure 3.
Metabolomic analysis of IBR-treated patient samples stimulated by CD40 or BCR. Heat map showing the abundance of 79 metabolites in CLL cells from 8 samples from patients with CLL at baseline or after 3-month treatment with IBR, which were restimulated by in vitro CD40/BCR for 24 hours. Metabolomic data were analyzed with Tercen software (https://www.tercen.com/) and are represented by z score followed with h clustering. Metabolic signatures induced by IBR treatment and CD40 and BCR stimulation are highlighted in black, yellow, and green, respectively. UN, unstimulated control.

Metabolomic analysis of IBR-treated patient samples stimulated by CD40 or BCR. Heat map showing the abundance of 79 metabolites in CLL cells from 8 samples from patients with CLL at baseline or after 3-month treatment with IBR, which were restimulated by in vitro CD40/BCR for 24 hours. Metabolomic data were analyzed with Tercen software (https://www.tercen.com/) and are represented by z score followed with h clustering. Metabolic signatures induced by IBR treatment and CD40 and BCR stimulation are highlighted in black, yellow, and green, respectively. UN, unstimulated control.

Close Modal

or Create an Account

Close Modal
Close Modal